Clincosm LogoSign in Get a demo

idh mutation

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Space Occupying Lesions of the Brain

Recruiting
  • Brain Tumor
  • +2 more
  • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
  • Bern, Switzerland
    Institute for Diagnostic and Interventional Neuroradiology, Univ
Jan 26, 2023

Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

Not yet recruiting
  • Glioma
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 22, 2022

Glioma, IDH Mutation Trial (BAY 2402234)

Withdrawn
  • Glioma
  • IDH Mutation
  • BAY 2402234
  • (no location specified)
Dec 17, 2021

Glioma, Cholangiocarcinoma, Solid Tumor Trial in Toronto (Olaparib, Durvalumab)

Recruiting
  • Glioma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 29, 2021

IDH Mutation, IDH1 Mutation, IDH2 Gene Mutation Trial in Chicago (Ivosidenib, Enasidenib, Fedratinib)

Recruiting
  • IDH Mutation
  • +4 more
  • Chicago, Illinois
    University of Chicago Medical Center
Nov 12, 2021

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021